Clearmind Medicine Inc. (CMND) stock
CMNDNasdaqPharmaceutical PreparationsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Score 5/30
$4.53−0.09 (-1.95%)
Close on Nov 13, 2026Market cap $716.08KP/E –Yield –
Clearmind Medicine EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for Clearmind Medicine
Clearmind Medicine has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?